Alnylam Pharmaceuticals, Inc(NASDAQ:ALNY) 
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, an...
Website: http://www.alnylam.com
Founded: 2002
Full Time Employees: 1,323
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 257.14
H 259.16
L 235.57
C 235.74
V 1,881,578
10EMA 235.74
20EMA 235.74
60EMA 235.74
120EMA 235.74
250EMA 235.74